SARAJEVO (Bosnia and Herzegovina), June 26 (SeeNews) – Bosnian drug maker Bosnalijek said on Tuesday its shareholders approved a dividend of 0.52 marka ($0.31/0.27 euro) per share for 2017, up slightly from 0.5 marka a year earlier.
The drug maker will distribute as dividend a total of 4.6 million marka from last year's earnings of 9.7 million marka, it said in a filing with the Sarajevo bourse.
Bosnalijek added it will use 2.1 million marka of its 2017 net profit to issue shares to its employees, while the remaining 3.1 million marka will be invested in the improvement and development of the company.
In October 2016, Bosnia's Federation government sold its 19.3% stake in Bosnalijek for 23.4 million marka to Malta-based financial services provider KBC Euro Credit Capital.
The Federation is one of the two autonomous entities that make up Bosnia and Herzegovina. The other one is the Serb Republic.
(1 euro=1.95583 marka)